TAM
Tiverton Asset Management’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $635K | Sell |
17,327
-284
| -2% | -$10.4K | 0.02% | 348 |
|
|
2019
Q2 | $819K | Sell |
17,611
-4,909
| -22% | -$228K | 0.03% | 299 |
|
|
2019
Q1 | $904K | Buy |
22,520
+940
| +4% | +$37.7K | 0.04% | 254 |
|
|
2018
Q4 | $992K | Sell |
21,580
-4,206
| -16% | -$193K | 0.06% | 179 |
|
|
2018
Q3 | $1.14M | Buy |
25,786
+22,199
| +619% | +$985K | 0.06% | 190 |
|
|
2018
Q2 | $140K | Sell |
3,587
-30,593
| -90% | -$1.19M | 0.01% | 353 |
|
|
2018
Q1 | $2.47M | Buy |
34,180
+25,786
| +307% | +$1.86M | 0.17% | 107 |
|
|
2017
Q4 | $553K | Sell |
8,394
-5,823
| -41% | -$384K | 0.03% | 233 |
|
|
2017
Q3 | $713K | Sell |
14,217
-1,877
| -12% | -$94.1K | 0.04% | 160 |
|
|
2017
Q2 | $745K | Sell |
16,094
-5,231
| -25% | -$242K | 0.04% | 166 |
|
|
2017
Q1 | $753K | Hold |
21,325
| – | – | 0.04% | 170 |
|
|
2016
Q4 | $267K | Hold |
21,325
| – | – | 0.02% | 187 |
|
|
2016
Q3 | $295K | Sell |
21,325
-34,738
| -62% | -$481K | 0.02% | 155 |
|
|
2016
Q2 | $2.94M | Sell |
56,063
-53,297
| -49% | -$2.79M | 0.12% | 124 |
|
|
2016
Q1 | $1.85M | Sell |
109,360
-11,195
| -9% | -$189K | 0.06% | 141 |
|
|
2015
Q4 | $2.68M | Sell |
120,555
-15,000
| -11% | -$334K | 0.09% | 133 |
|
|
2015
Q3 | $3.2M | Hold |
135,555
| – | – | 0.07% | 136 |
|
|
2015
Q2 | $11.1M | Buy |
135,555
+25,455
| +23% | +$2.08M | 0.22% | 105 |
|
|
2015
Q1 | $10.2M | Buy |
+110,100
| New | +$10.2M | 0.21% | 103 |
|